PFIZER INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pfizer Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Pfizer Inc Income Tax Expense (Benefit) for the quarter ending September 29, 2024 was $234M.
  • Pfizer Inc Income Tax Expense (Benefit) for the twelve months ending September 29, 2024 was -$402M, a 347% decline year-over-year.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2023 was -$1.12B, a 134% decline from 2022.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2022 was $3.33B, a 79.7% increase from 2021.
  • Pfizer Inc annual Income Tax Expense (Benefit) for 2021 was $1.85B, a 401% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$402M $234M +$1.2B Jul 1, 2024 Sep 29, 2024 10-Q 2024-11-04
Q2 2024 -$1.6B -$134M -$63M -88.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$1.54B $293M -$422M -59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$1.12B -$795M -$1.03B -446% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$90M -$964M -$1.32B -371% Jul 3, 2023 Oct 1, 2023 10-Q 2024-11-04
Q2 2023 $1.23B -$71M -$1.64B -105% Apr 3, 2023 Jul 2, 2023 10-Q 2024-08-05
Q1 2023 $2.87B $715M -$457M -39% Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q4 2022 $3.33B $230M -$19M -7.63% Oct 3, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $3.35B $356M +$684M Jul 4, 2022 Oct 2, 2022 10-Q 2023-11-08
Q2 2022 $2.66B $1.57B +$447M +39.8% Apr 4, 2022 Jul 3, 2022 10-Q 2023-08-09
Q1 2022 $2.22B $1.17B +$364M +45.1% Jan 1, 2022 Apr 3, 2022 10-Q 2023-05-10
Q4 2021 $1.85B $249M +$313M Oct 4, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.54B -$328M +$19M +5.48% Jul 5, 2021 Oct 3, 2021 10-Q 2022-11-09
Q2 2021 $1.52B $1.12B +$701M +166% Apr 5, 2021 Jul 4, 2021 10-Q 2022-08-10
Q1 2021 $819M $808M +$449M +125% Jan 1, 2021 Apr 4, 2021 10-Q 2022-05-11
Q4 2020 $370M -$64M +$1.92B +96.8% Sep 28, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$1.55B -$347M -$3.39B -111% Jun 29, 2020 Sep 27, 2020 10-Q 2021-11-12
Q2 2020 $1.85B $422M +$1.34B Mar 30, 2020 Jun 28, 2020 10-Q 2021-08-12
Q1 2020 $509M $359M -$74M -17.1% Jan 1, 2020 Mar 29, 2020 10-Q 2021-05-13
Q4 2019 $583M -$1.98B -$446M -29% Sep 30, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.03B $3.05B +$2.98B +4517% Jul 1, 2019 Sep 29, 2019 10-Q 2020-11-05
Q2 2019 -$1.95B -$915M -$1.56B -241% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$389M $433M -$123M -22.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$266M -$1.54B +$9.8B +86.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$10.1B $66M -$661M -90.9% Jul 2, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$9.41B $648M -$91M -12.3% Apr 2, 2018 Jul 1, 2018 10-Q 2019-08-08
Q1 2018 -$9.31B $556M -$265M -32.3% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-09
Q4 2017 -$9.05B -$11.3B -$11.4B -81071% Oct 2, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $2.3B $727M +$478M +192% Jul 3, 2017 Oct 1, 2017 10-Q 2018-11-08
Q2 2017 $1.82B $739M +$392M +113% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-09
Q1 2017 $1.43B $821M +$308M +60% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-10
Q4 2016 $1.12B $14M +$202M Oct 3, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $921M $249M -$318M -56.1% Jul 4, 2016 Oct 2, 2016 10-Q 2017-11-09
Q2 2016 $1.24B $347M -$558M -61.7% Apr 4, 2016 Jul 3, 2016 10-Q 2017-08-10
Q1 2016 $1.8B $513M -$193M -27.3% Jan 1, 2016 Apr 3, 2016 10-Q 2017-05-11
Q4 2015 $1.99B -$188M -$733M -134% Sep 28, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $2.72B $567M -$344M -37.8% Jun 29, 2015 Sep 27, 2015 10-Q 2016-11-10
Q2 2015 $3.07B $905M -$177M -16.4% Mar 30, 2015 Jun 28, 2015 10-Q 2016-08-11
Q1 2015 $3.24B $706M +$124M +21.3% Jan 1, 2015 Mar 29, 2015 10-Q 2016-05-12
Q4 2014 $3.12B $545M +$115M +26.7% Sep 29, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $3.01B $911M -$74M -7.51% Jun 30, 2014 Sep 28, 2014 10-Q 2015-11-05
Q2 2014 $3.08B $1.08B -$700M -39.3% Mar 31, 2014 Jun 29, 2014 10-Q 2015-08-06
Q1 2014 $3.78B $582M -$527M -47.5% Jan 1, 2014 Mar 30, 2014 10-Q 2015-05-07
Q4 2013 $4.31B $430M -$83M -16.2% Sep 30, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $4.39B $985M +$1.17B Jul 1, 2013 Sep 29, 2013 10-Q 2014-11-06
Q2 2013 $3.22B $1.78B +$602M +51% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.62B $1.11B +$398M +56% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $2.22B $513M +$96M +23% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $2.13B -$183M -$1.4B -115% Jul 2, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $3.52B $1.18B +$86M +7.86% Apr 2, 2012 Jul 1, 2012 10-Q 2013-08-09
Q1 2012 $3.44B $711M -$183M -20.5% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q4 2011 $3.62B $417M +$2.43B Oct 3, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $1.19B $1.22B +$658M +118% Jul 4, 2011 Oct 2, 2011 10-Q 2012-11-09
Q2 2011 $534M $1.09B -$378M -25.7% Apr 4, 2011 Jul 3, 2011 10-Q 2011-08-11
Q1 2011 $912M $894M -$241M -21.2% Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q4 2010 $1.15B -$2.01B Oct 4, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $558M Jul 5, 2010 Oct 3, 2010 10-Q 2011-11-10
Q2 2010 $1.47B Apr 5, 2010 Jul 4, 2010 10-Q 2011-08-11
Q1 2010 $1.14B Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.